Quick Links
Top Searched Items
Advanced Business Search
This Glendale home health care agency is licensed by the California Department of Public Health. It offers home health aide services, medical social services, occupational therapy, physical therapy and speech therapy.
Comprehensive medical practice in prime downtown DC location with loyal patient base. Practice also receives a sizable and stable revenue stream from drug studies; physician-owner would help transition long-standing drug company relationship to new practitioner.
This congregate living facility is licensed by the Department of Public Health for 6 residents with 4 private rooms and 1 shared room. It also has Medi-Cal provider number and it has a clinical laboratory registration. All of the facility’s hospital beds are of advanced design and offer an incredible comfort level. The facility is equipped with a professional kitchen that has an industrial dishwasher, per new Department of Public Health requirements. At the moment there are no residents on premise.Training: 2 Weeks at 20 hours/week.
This Glendale home health care agency is licensed by the California Department of Public Health. The Joint Commission fee is paid. In addition, this agency has contracts with 3 medical groups and contracts with staffing companies in Los Angeles, Orange and Riverside Counties to provide care to patients as needed. Contracts with durable medical equipment (DME) companies are also in place.Training: 2 Weeks at 20 hours/week.
17 years in the same location in densely populated section of Queens. While there's a major hospital 10 minutes away this is the only internal medicine practice we know of for several blocks. Located DIRECTLY across the street from the largest apartment complex in the city.
SAVE TIME AND MONEY by purchasing our newly established Homecare Agency / Health Care Services Firm ( HCSF ) with Accreditation and Medicaid provider #, saving you over a year of wait time and uncertainty, along with costly lawyers, consultants, accountants, staff salaries, space expenses etc etc. Presently anchored by a Registered Nurse seeking to remain at her hospital position, this gives you an opportunity to commence operations immediately and take over the compliant, liability free infrastructure.
Patented Universal Tumor-Targeting Drug Delivery Platform Co.This pharmaceutical company has developed and patented a universal tumor-targeting drug-delivery platform that can improve the safety and efficacy of many existing chemo treatments, with the ability to target numerous different types of cancer. The technology encapsulates existing FDA-approved drugs inside lipid nanoparticles (liposomes or emulsions) coated with patented human-sourced antinuclear antibodies (ANA). The lipid nanoparticle provides long-term storage stability of the drug and controlled release of the drug over time at body-temperature, and is expected to improve the safety and efficacy profile of the drug, including passive accumulation at the tumor while not harming normal tissues. The Company’s ANA, sourced from lupus patients, binds to nuclear material present in abundance in areas of necrosis (dead / ruptured cells) present in and around all solid tumors, thus anchoring the drug-filled nanoparticles at the tumor where the nanoparticle is designed to slowly release the drug directly on the tumor for more effect. As the Company’s ANA is not tumor-marker specific, but rather targets necrosis present in solid tumors, the technology is designed to 'universally' target many different types of cancer including breast cancer, lung, ovarian, colon, prostate, etc., as well as rare childhood cancers.The Company completed a successful proof-of-concept study at Children's Hospital using Ewing's Sarcoma transplanted in immunodeficient mice. Treatment with the Company's forumlation significantly inhibited tumor growth and extended survival times compared to control mice receiving no treatment or treatment with plain liposomal doxorubicin.The Company has been granted Orphan Drug Designation by the FDA on 2 of the lead drug formulations, providing FDA fee waivers, priority review, and 7-years exclusivity upon market approval. The orphan pathway also enables the potential for New Drug Approval after successful completion of Phase 2 studies, with Phase III data collected while in the market, thus significantly lowering the time and cost to market approval. This same drug inside the Company's tumor targeting delivery system will likely have potential to treat other pediatric cancers, and/or cancers in larger adult populations.As the Company’s platform and ANA has the potential to improve the safety and efficacy of many existing FDA approved drugs or even compounds in development, the Company anticipates the potential for multiple licensing agreements with multiple pharmaceutical companies seeking to improve their existing portfolio and extend patient life as they advance into clinical stage. And as it may be possible to file for New Drug Approval following successful Phase II studies, the Company anticipates licensing potential at early clinical stage. Multiple exit opportunities exist with high impact & high ROI.The Company is seeking a supportive capital partner to maintain momentum up to $20M. Funding will be used to advance the lead drug through formal Investigational New Drug enabling studies towards New Drug Approval; estimating $3-5 Million now to advance into clinical studies. Preclinical / animal studies estimate ($3 - 5 Million and 12-18 months); followed by potential combined Phase I-II clinical study in a rare cancer (approximately 2-3 years and $10M) to potential New Drug Approval, plus additional capital to advance additional drugs in the pipeline simultaneously, thus adding tremendous value to the Company’s valuation. Valuations of pharma companies often exceed $100 Million valuation at Phase I (approximately 18 months), and New Drug Approval can exceed valuations above $1 Billion. The Company has numerous, improved high-impact cancer drugs advancing with proper support.NDA is required for comprehensive Confidential Information Memorandum crafted by ProNova Partners.
The Company has proprietary technology that addresses a leading cause of maternal death (76,000) and fetal death (500,000) annually worldwide. 8% of pregnancies in the US and 14% worldwide have diagnoses that would be vastly improved by worldwide commercialization of the Company's proprietary device. A very low risk procedure that both provides quality of life improvement for the mother & baby and lowers health care costs is a win/win/win for all involved. Existing collaborations with major manufacturers coupled with a current expedited approval process with the FDA presents a tremendous opportunity for individuals or private equity groups seeking a transformative investment into a feel-good biotech story with exceptional legs and a vast runway with nearly unlimited upside. Able to work with groups/individuals in tranches of $500,000 to $1MM to advance into the pilot clinical study, $2-$3MM for the pivotal clinical study towards market approval in the US. They will seek direct sales with partnered hospitals, licensing / partnership deals could utlimately yield the balance of funding to fully deploy a commercial version of the technology. NDA is required for comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
UNIQUE BUSINESS WITH GREAT REIMBURSEMENT RATES!_CHEAP RENT, LONG TERM LEASE, TURN KEY ADSC, ZERO DOWN! Seller provides All necessary Gov't approved permits and licenses to operate and get reimbursed. Experienced qualified staff! Average reimbursement is $80 per day per person! Services rendered: Personal care services Care management Therapeutic recreation Ethic and religious programs Special events Support groups Meals and snacks plus the support of a Registered Dietitian Social Work Services/entitlement counseling. Transportation Services. Perfect location for Social Daycare target audience. Average reimbursement is $80 per day per person. Competition: Unique to the area and industry, excellent reimbursement agreements with Managed Care Company. Seller could divide or expand capacity and /or add other related Medicare reimbursable services to same consumer population as part of this deal
MAKE OFFERS!! Buy the simplest profit making setup: very low overhead, Medicare reimbursement, ability to add other diagnostic testing services...no need to look for individual patients, only 'accounts' to service, usually physicians outsourcing the tests. In light of Federal Anti Markup regulation, Family/ Non Specialty Doctors may no longer bill Medicare at profit, and have to charge 'at cost'. Majority of them dont like the hassle of billing tests by themselves, particularly without making any profit. Hence, they hire entities such as this one (Mobile IDTF) to perform tests on their patients, and at their offices. Usual business arrangement includes IDTF paying fair market rent to the Doctor, and possibly some ancillary fees, such as secretarial support, etc.
Make an Offer!! We created a 'shell' Home Health Agency, enabled to operate in the State of Texas from a staffing and licensing compliance standpoint. We have already procured the license and have the requisite approvals in place. It is relocatable to anywhere in Texas. Save Time and Money!! The Agency is not a franchise, and 100% of the ownership and proceeds shall remain with you. We provide one year of operational support. We have being doing this for 18 years and have launched hundreds of projects nationwide. We guarantee delivered performance before it asks to be paid. Make an Offer!! We Will Answer Your Questions And Train You Adequately so you Feel Secure And Competent.
Buy the simplest profit making setup: very low overhead, Medicare reimbursement, ability to add other diagnostic testing services...no need to look for individual patients, only 'accounts' to service, usually physicians outsourcing the tests.__ In light of Federal Anti Markup regulation, Family/ Non Specialty Drs may no longer bill Medicare at profit, and have to charge 'at cost'. Majority of them dont like the hassle of billing tests by themselves, particularly w/o making any profit. Hence, they hire entities such as this one (Mobile IDTF) to perform tests on their patients, and at their offices.
We are selling an Independent Diagnostic Testing Facility Medicare provider # (IDTF) certificate to operate, approved by Dept of Health as well. It is a 'license'sale with certification license as a sole value. You can get paid from Medicare and private insurances for any medical test you perform. Elderly market is on the up rise. Medicare pays well for many tests. You can do mobile tests, across the State, which means you can deliver the testing equipment such as sonogram or other types to the Doctor office and get paid directly from patient's insurance. Most Doctors don’t have ALL the testing equipment of their own, so you can offer those types that they are missing. Doctor makes money off your tests as well, since Doctor gets to treat the diagnosed condition, without spending money on equipment, and without sending his patients outside his practice.
Okay
Please Confirm
Are you sure you wish to REMOVE from your request basket?
Save Your Search Results
If you have listings on our site or you have a Listings By Email account, you can use your same login credentials below. Log in to your account to save your search(es).
Create your FREE Listings By Email Account
Simply enter your email address for your account. Once verified, your password will be immediately sent to you at this email address.
Password reset link has been sent out, you can click and create a new password.
We're Sorry
We only allow businesses per information request. Please complete your current requests to continue.
Complete Requests »
Oops!
Wow, glad you're interested in so many businesses! The you've inquired to will contact you shortly.
Sounds Good
Learn how you can create the life you want. Small business financing with Guidant Financial
Business Funding From Guidant Financial
Thank you for Business Funding Pre-Qualification Request.
You should receive an email response within a hour
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.
Asking Price: $125,000
